A Patient’s Reported Tic Improvement Was Different From a Two-Day Cannabis Comparison
The Tourette case included a patient’s report of more than 90% tic improvement over his treatment history, while formal scores showed a narrower difference across two assessed days. The percentages and scores did not share the same baseline.
The long-term description was patient-reported
The man described substantial improvement after beginning cannabis use years earlier. That account supplied clinical history and a reason to investigate his functioning. It was not a prospectively measured percentage change from a standardized untreated baseline in the reported experiment.
The two-day scores answered another question
Formal tic measures were somewhat better on the day with cannabis intake than on the next day without additional intake before assessment. The table reports total tic scores of 38 and 41, while global severity and video-rated measures also differed. The global measure includes broader impairment, so it should not be treated as an interchangeable tic count.
Do not use one comparison to authenticate the other
A modest two-day difference does not independently verify a more-than-90% long-term reduction, and it does not disprove the patient’s historical experience either. The observation periods, baselines and measurement methods differ. Both days also followed an established exposure history. This case supplies neither randomized treatment efficacy nor a drug-free natural-history comparison. Its useful contribution is a carefully described clinical observation in which patient history, formal symptom ratings and functional testing can be examined separately rather than collapsed into one improvement statistic.
Related analysis: the serum THC and driving-related findings in this case.
Research cited
Streetz and colleagues. Case Report: Effect of medicinal cannabis on fitness to drive in a patient with Tourette Syndrome and ADHD. Frontiers in Psychiatry (2025). DOI: 10.3389/fpsyt.2025.1595649.
